Abstract
Antifungal susceptibility testing has become an important tool for physicians faced with making difficult treatment decisions regarding treatment of patients with fungal infections. The Clinical Laboratory and Standards Institute (CLSI) has approved methods for testing of both yeast and moulds. Testing may be accomplished via macrobroth, microbroth, or disk methods. In addition to CLSI methods, industry has provided a variety of both manual and automated systems for determining antifungal susceptibility for fungi. This, combined with an expanded list of interpretive data, has elevated antifungal susceptibility testing to a level of importance as a diagnostic test.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
CLSI (2008a) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition; CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne
CLSI (2008b) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne
CLSI (2009) Method for antifungal disk diffusion susceptibility testing of filamentous fungi; proposed guideline. CLSI document M51-P. Clinical and Laboratory Standards Institute, Wayne
NCCLS (2004) Reference method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline. NCCLS document M44-A. National Committee for Clinical Laboratory Standards, Wayne
NCCLS (1985) Antifungal susceptibility testing; committee report. NCCLS document M20-CR. NCCLS, Villanova
NCCLS (1992) Reference method for broth dilution antifungal susceptibility testing of yeasts; proposed standard NCCLS document M27-P. National Committee for Clinical Laboratory Standards, Wayne
NCCLS (2002) Reference method for broth dilution antifungal susceptibility testing of conidial-forming filamentous fungi. Approved standard NCCLS M38-A. National Committee for Clinical Laboratory Standards, Wayne
Odds FC, Motyl M, Andrade R et al (2004) Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol 42:3475–3482
Espinel-Ingroff A (2003) Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). J Clin Microbiol 41:403–409
Espinel-Ingroff A, Fothergill A, Ghannoum MA, Manavathu E, Ostrosky-Zeichner L, Pfaller M, Rinaldi M, Schell W, Walsh T (2007) Quality control and reference guidelines for CLSI broth micro-dilution method (M38-A document) for susceptibility testing of anidulafungin against moulds. J Clin Microbiol 45(7):2180–2182
Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL et al (2005) International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 43(8):3884–3889
Pappagianis D, Collins MS, Hector R, Remington J (1979) Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 16:123–126
Merz WG (1984) Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 20:1194–1195
Rex JH, Pfaller MA (2002) Has antifungal susceptibility testing come of age? Clin Infect Dis 35(8):982–989
Barry A, Bille J, Brown S, Ellis D, Meis J, Pfaller M et al (2003) Quality control limits from fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J Clin Microbiol 41(7):3410–3412
Espinel-Ingroff A, Pfaller M, Messer SA, Knapp CC, Holliday N, Killian SB (2004) Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference methods for testing new antifungal agents against clinical isolates of Candida spp. J Clin Microbiol 42(2):718–721
Maxwell MJ, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Diekema DJ et al (2003) Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood. J Clin Microbiol 41(3):1087–1090
Maxwell MJ, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA (2003) Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans. J Clin Microbiol 41(1):97–99
Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, Ellis D, Pfaller MA, Messer S, Rinaldi M, Fothergill A, Gibbs D, Wang A (2007) Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol 45(6):1811–1820
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Fothergill, A.W. (2012). Antifungal Susceptibility Testing: Clinical Laboratory and Standards Institute (CLSI) Methods. In: Hall, G. (eds) Interactions of Yeasts, Moulds, and Antifungal Agents. Humana Press. https://doi.org/10.1007/978-1-59745-134-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-59745-134-5_2
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-847-8
Online ISBN: 978-1-59745-134-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)